Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by José Baselga
Author Correction: HER Kinase Inhibition in Patients With HER2- And HER3-mutant Cancers
Nature
Multidisciplinary
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Cancer Discovery
Oncology
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Cancer Discovery
Oncology
Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients With Systemic Histiocytic Disorders
Cancer Discovery
Oncology
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Constitutive HER2 Signaling Promotes Breast Cancer Metastasis Through Cellular Senescence
Cancer Research
Cancer Research
Oncology
AKT Signaling in ERBB2-amplified Breast Cancer
Pharmacology and Therapeutics
Pharmacology
Pregnancies During and After Trastuzumab and/or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Analysis From the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) Trials
Cancer
Cancer Research
Oncology
Synergy Between Trastuzumab and Pertuzumab for Human Epidermal Growth Factor 2 (Her2) From Colocalization: An in Silicobased Mechanism
Breast Cancer Research
Cancer Research
Oncology
1
2
›
